Thus, the experimental HFD setup used in our study resulted in hyperinsulinemia and hepatosteatosis associated with specific changes in enhancer activity and gene transcription likely regulated by transcription factors such as SREBP, ATF-4 and C/EBP. The gene discussed is ATF4; the disease is Hyperinsulinemia.